A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before
Prevalence rate of diabetes mellitus worldwide and in Russian Federation is epidemic in its nature. Prospective studies have shown thatmaintenance of glycemic target reduces risk of late vascular complications. In turn, strict glycemic control requires modern approach tointensification of glucose lo...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2012-03-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5981 |
| _version_ | 1797255263198117888 |
|---|---|
| author | Marina Vladimirovna Shestakova |
| author_facet | Marina Vladimirovna Shestakova |
| author_sort | Marina Vladimirovna Shestakova |
| collection | DOAJ |
| description | Prevalence rate of diabetes mellitus worldwide and in Russian Federation is epidemic in its nature. Prospective studies have shown thatmaintenance of glycemic target reduces risk of late vascular complications. In turn, strict glycemic control requires modern approach tointensification of glucose lowering therapy. Randomized clinical trials prove capacity of modern insulin analogues to improve glycemiccontrol while decreasing risk of hypoglycemic events and weight gain. Current paper presents initial data on 9342 patients, participatedin multicenter prospective 52-week observational study A1chieve, conducted in order to assess efficiency and safety of treatment withinsulin analogues Levemir?, NovoMix? and NovoRapid? (Novo Nordisk) in daily management of patients with type 2 diabetes mellitus,who never received that treatment before. |
| first_indexed | 2024-03-08T15:21:04Z |
| format | Article |
| id | doaj.art-35253e7c4a53459592ef9b11416ba12a |
| institution | Directory Open Access Journal |
| issn | 2072-0351 2072-0378 |
| language | English |
| last_indexed | 2024-04-24T22:03:04Z |
| publishDate | 2012-03-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj.art-35253e7c4a53459592ef9b11416ba12a2024-03-20T11:47:57ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782012-03-01151637010.14341/2072-0351-59815939A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it beforeMarina Vladimirovna Shestakova0Endocrinology Research Centre, MoscowPrevalence rate of diabetes mellitus worldwide and in Russian Federation is epidemic in its nature. Prospective studies have shown thatmaintenance of glycemic target reduces risk of late vascular complications. In turn, strict glycemic control requires modern approach tointensification of glucose lowering therapy. Randomized clinical trials prove capacity of modern insulin analogues to improve glycemiccontrol while decreasing risk of hypoglycemic events and weight gain. Current paper presents initial data on 9342 patients, participatedin multicenter prospective 52-week observational study A1chieve, conducted in order to assess efficiency and safety of treatment withinsulin analogues Levemir?, NovoMix? and NovoRapid? (Novo Nordisk) in daily management of patients with type 2 diabetes mellitus,who never received that treatment before.https://www.dia-endojournals.ru/jour/article/view/5981diabetes mellitus type 2observational study a1chieveinsulin analogues |
| spellingShingle | Marina Vladimirovna Shestakova A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before Сахарный диабет diabetes mellitus type 2 observational study a1chieve insulin analogues |
| title | A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_full | A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_fullStr | A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_full_unstemmed | A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_short | A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before |
| title_sort | a1chieve program in russian federation a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus who startand intensify insulin treatment having never received it before |
| topic | diabetes mellitus type 2 observational study a1chieve insulin analogues |
| url | https://www.dia-endojournals.ru/jour/article/view/5981 |
| work_keys_str_mv | AT marinavladimirovnashestakova a1chieveprograminrussianfederationamulticenterprospectiveobservationalstudyofinsulinanaloguetreatmentefficiencyandsafetyindailymanagementofpatientswithtype2diabetesmellituswhostartandintensifyinsulintreatmenthavingneverreceiveditbefore |